Home › Markets › Health Care › PMVP

PMV Pharmaceuticals Inc. (PMVP)

PMVP trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$1.35
-4.25% on the day
Market cap
$101.9M
Micro cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.

Profile

FieldValue
TickerPMVP on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2020
SEC CIK0001699382
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

Not reported in SEC XBRL data.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-09-02
Latest annual report10-K2026-03-06
Latest quarterly / interim10-Q2026-08-14
Latest current report8-K2026-10-05
Latest proxyDEFA14A2026-04-22

Source: SEC EDGAR submissions feed, 390 recent filings. All filings on EDGAR.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
RANIRani Therapeutics Holdings Inc.$0.7332-2.36%$102.2M
INOInovio Pharmaceuticals Inc.$0.9982-9.66%$103.2M
UNCYUnicycive Therapeutics Inc.$3.73-7.90%$103.9M
COYACoya Therapeutics Inc.$4.47-6.96%$105.0M
TNXPTonix Pharmaceuticals Holding Corp.$6.13-7.68%$105.1M
QUCYQuantum Cyber N.V.$1.12+8.74%$97.7M
CPIXCumberland Pharmaceuticals Inc.$7.17+2.43%$107.4M
PLYXPolaryx Therapeutics Inc.$1.94-3.48%$96.7M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier